| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | — | — | — | — | — | — |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 3.62 | 16.77 | 12.37 | 11.50 |
| Receivables | 0.00 | — | 0.08 | 0.12 |
| Inventory | — | — | — | — |
| Other | — | — | — | — |
| 3.64 | 16.83 | 12.60 | 11.89 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 0.22 | 0.34 | 0.27 | 0.33 |
| ST’ Debt | — | — | — | — |
| Other | — | — | — | — |
| 0.27 | 0.40 | 0.68 | 1.13 |
| 10y | 5y | 3y | |
| Sales | — | — | — |
| Cash Flow | — | — | ‡‡‡ |
| Earnings | — | — | ‡‡‡ |
| Book Value | — | — | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 1.81 | 2.46 | — | — |
—
|
| ’25 | 0.02 | 0.17 | 0.50 | 1.24 |
1.93
|
| ’24 | 0.00 | — | 0.00 | 0.00 |
0.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (2.49) | (1.09) | — | — |
—
|
| ’25 | (1.30) | (0.72) | (1.11) | (0.73) |
(3.85)
|
| ’24 | (1.10) | (0.74) | (0.67) | (0.77) |
(3.28)
|
| ’23 | (0.93) | (0.50) | (0.87) | (0.67) |
(2.98)
|
| ’22 | (0.19) | (0.40) | (0.32) | (0.36) |
(1.26)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (2.50) | (1.09) | — | — |
—
|
| ’25 | (1.82) | (0.74) | (1.13) | (0.75) |
(4.44)
|
| ’24 | (1.27) | (0.74) | (0.67) | (0.79) |
(3.48)
|
| ’23 | (0.93) | (0.50) | (0.90) | (0.71) |
(3.04)
|
| ’22 | (0.19) | (0.40) | (0.38) | (0.36) |
(1.32)
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | (0.25) | 0.02 | — | — |
—
|
| ’25 | (0.17) | (0.11) | (0.14) | (0.13) |
(0.55)
|
| ’24 | (0.91) | (0.72) | (0.61) | — |
(1.92)
|
| ’23 | (0.14) | (0.06) | (0.07) | — |
(4.00)
|
| ’22 | — | — | (0.03) | (0.03) |
(0.12)
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | 3.23 | 1.01 | 1.00 | — | — | — |
Low Price
|
| — | — | — | — | — | — | — | 61.80 | 19.20 | 3.36 | — | — | — |
High Price
|
| — | — | — | — | — | ‡‡‡ | 3 | 3 | 3 | 3 | — | — | — |
Employees
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.64 | — | — | — |
Revenue/Emp
|
| — | — | — | — | — | — | — | 0.00 | 0.00 | 1.93 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue
|
| — | — | — | — | — | — | 0.00% | 100.00% | 100.00% | 100.00% | — | — | — |
Gross Margin
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.42) | (3.95) | (3.42) | (4.28) | — | — | — |
EBT
|
| — | — | — | — | — | ‡‡‡ | 0.00% | (1,316,033.33%) | (85,607.50%) | (221.53%) | ‡‡‡ | ‡‡‡ | — |
EBT Margin
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.42) | (3.95) | (3.42) | (4.28) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Net Income
|
| — | — | — | — | — | — | 0.00 | 0.01 | 0.05 | 0.20 | — | — | — |
Depreciation
|
| — | — | — | — | — | ‡‡‡ | 0.00 | 0.00 | 0.00 | 0.27 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Revenue/Sh
|
| — | — | — | — | — | ‡‡‡ | (0.12) | (4.00) | (1.92) | (0.55) | ‡‡‡‡ | ‡‡‡‡‡ | — |
Earnings/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.45) | (3.02) | (1.84) | (0.54) | — | — | — |
Cash Flow/Sh
|
| — | — | — | — | — | ‡‡‡ | (0.07) | (0.06) | (0.11) | (0.08) | ‡‡‡ | ‡‡‡ | — |
Capex/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.52) | (3.07) | (1.95) | (0.63) | — | — | — |
Free CF/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.79 | 3.47 | 9.35 | 1.80 | — | — | — |
Book Value/Sh
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.87 | 0.99 | 1.78 | 7.09 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Shares
|
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
PE Ratio
|
| — | — | — | — | — | — | — | 0.00 | 0.00 | 3.93 | ‡‡‡ | ‡‡‡ | — |
PS Ratio
|
| — | — | — | — | — | — | — | 1.17 | 0.27 | 0.60 | ‡‡‡ | ‡‡‡ | — |
PB Ratio
|
| — | — | — | — | — | — | — | 0.00 | 0.00 | (2.47) | ‡‡‡‡ | ‡‡‡‡ | — |
EV/Sales
|
| — | — | — | — | — | — | — | (0.14) | 3.51 | 1.08 | — | — | — |
EV/FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.26) | (2.98) | (3.28) | (3.85) | ‡‡‡ | ‡‡‡ | — |
Op' Cash Flow
|
| — | — | — | — | — | — | (0.06) | (0.06) | (0.20) | (0.58) | — | — | — |
Capex
|
| — | — | — | — | — | ‡‡‡‡‡ | (1.32) | (3.04) | (3.48) | (4.44) | — | — | — |
FCF
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.63 | 3.37 | 16.43 | 11.92 | — | — | — |
Working Cap'
|
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Total Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | (0.68) | (3.62) | (16.77) | (12.37) | — | — | — |
Net Debt
|
| — | — | — | — | — | ‡‡‡‡‡ | 0.69 | 3.43 | 16.62 | 12.74 | — | — | — |
Sh' Equity
|
| — | — | — | — | — | ‡‡‡ | (94.13%) | (170.28%) | (32.99%) | (25.62%) | — | — | — |
ROA
|
| — | — | — | — | — | ‡‡‡ | (15,085.81%) | 0.00% | 0.00% | (819.42%) | — | — | — |
ROIC
|
| — | — | — | — | — | ‡‡‡ | (103.17%) | (192.05%) | (34.10%) | (26.57%) | — | — | — |
ROE
|
Gaxos.ai Inc. (GXAI), a microcap AI player with a tiny team, has ignited retail excitement with explosive revenue growth—from $300,000 in 2023 to $4 million in 2024, a staggering 1,233% surge—signaling potential as an early-stage disruptor in gaming and data AI solutions. Revenue per employee leaped accordingly, hinting at scalable tech amid the post-ChatGPT boom. Yet, persistent deep losses (net income at -$3.42 million in 2024), massive share dilution (80% increase in 2024), and stomach-churning stock volatility temper the hype, though a pristine balance sheet—no debt and a net cash position swelling to $16.77 million—provides crucial runway.
Analyst forecasts project hypergrowth continuation: revenue exploding to $1.69 million in 2025 (42,150% jump) and stabilizing near $3.4 million by 2027, with margins trending toward breakeven (0% EBT). Losses are narrowing—EPS halved from -$4.00 to -$1.92—and efficiency metrics like ROE and ROA are improving, but negative cash flows and dilution persist. The stock’s Nasdaq uplisting sparked spikes, yet it’s now undervalued on book value (PB 0.27) and future EV/Sales (down to 2.45x), with unanimous analyst targets implying 135% upside.
This high-risk, high-reward moonshot echoes volatile microcap AI tales of the past: rewarding for speculative portfolios if revenue inflections hold and AI tailwinds endure, but vulnerable to dilution, macro pressures, and growth misses. No insider action adds caution, yet the cash buffer and beaten-down entry point whisper opportunity—read the full analysis for the charts, risks, and historical parallels that could make or break GXAI’s trajectory.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.